What does the NOPP indicate about the sale of PHI?

The NOPP clearly states that Protected Health Information (PHI) cannot be sold for commercial purposes without obtaining the patient's explicit authorization. This provision is rooted in the principle of protecting patient privacy and ensuring that individuals have control over their personal health information. Patients must be informed about how their health information may be used or disclosed, and they have the right to consent before any sale occurs. This safeguard helps maintain trust in healthcare practices and ensures compliance with privacy regulations. The other options misrepresent the ethical and legal standards surrounding the handling of PHI.